PHARMACEUTICAL COMPOSITION FOR MODULATING THE RESPONSE OF A GABA-A RECEPTOR
申请人:Universität Wien
公开号:EP3498273A1
公开(公告)日:2019-06-19
The present invention relates to a pharmaceutical composition for use as a medicament and to the use of the pharmaceutical composition for modulating the response of a GABAA receptor and the treatment of conditions like insomnia, anxiety, cardiac disease and/or epilepsy. Furthermore, the present invention refers to new active agents suitable for said pharmaceutical compositions.
Novel sulfamides of formula (1) are disclosed. The compounds exert an inhibitory action on the processing of APP by gamma-secretase, and are therefore useful in the treatment or prevention of Alzheimer's disease.
Metal-free C–N bond-forming reaction: straightforward synthesis of anilines, through cleavage of aryl C–O bond and amide C–N bond
作者:Jianzhong Yu、Peizhi Zhang、Jun Wu、Zhicai Shang
DOI:10.1016/j.tetlet.2013.04.028
日期:2013.6
An efficient metal-free C-N bond forming reaction through cleavage of aryl C-O bond and amide C-N bond has been developed. This process represents a practical method for the facile construction of anilines with a broad substrate scope and wide functional group tolerance in moderate to excellent yields. (C) 2013 Elsevier Ltd. All rights reserved.